Philip W. Kantoff insider trades

Open-market stock purchases and sales by Philip W. Kantoff, Director at Context Therapeutics Inc, from SEC Form 4 filings since Jun 2, 2022.

Recent trades

DateStockTradeValue
Jun 24, 2026CNTX Context Therapeutics IncBought (not open market)—

Companies traded

  • CNTX Context Therapeutics Inc: other filings, last Jun 24, 2026
  • EPIX ESSA Pharma Inc: other filings, last Mar 25, 2024

Get free alerts when Philip W. Kantoff files a new trade →